Publicaciones (18) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. Aflibercept for metastatic colorectal cancer: Safety data from the Spanish named patient program

    Expert Opinion on Drug Safety, Vol. 14, Núm. 8, pp. 1171-1179

  2. BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

    Scientific Reports, Vol. 5

  3. Cambios en la calidad de vida de personas en tratamiento con quimioterapia adyuvante ambulatoria

    Metas de enfermería, Vol. 18, Núm. 7

  4. Coste del tratamiento del cáncer de mama por estadío clínico en el País Vasco

    Revista Espanola de Salud Publica, Vol. 89, Núm. 1, pp. 93-97

  5. EUFOR Chad/CAR Mission on the Protection of Civilians: A Distinctive EU Way to Peace Operations

    Rethinking Peace and Conflict Studies (Palgrave Macmillan), pp. 216-235

  6. Efficacy and safety of fixed-dose-rate infusions of gemcitabine plus erlotinib for advanced pancreatic cancer

    Journal of Analytical Oncology, Vol. 4, Núm. 1, pp. 44-51

  7. Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

    BMC Cancer, Vol. 15, Núm. 1

  8. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies

    Oncotarget, Vol. 6, Núm. 42, pp. 44254-44273

  9. Histiocitosis X, diagnóstico por criobiopsia: A propósito de un caso

    Revista de la Asociacion Espanola de Especialistas en Medicina del Trabajo, Vol. 24, Núm. 1, pp. 36-40

  10. Introduction. Venous thromboembolism in patients with cancer

    Medicina Clinica

  11. Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP

    Experimental and Molecular Pathology, Vol. 99, Núm. 3, pp. 537-545

  12. MicroRNAs as B-cell lymphoma biomarkers

    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, Vol. 5, pp. 25-34

  13. Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design

    Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315

  14. Prolonged survival with erlotinib followed by afatinib in a caucasian smoker with metastatic, poorly differentiated large cell carcinoma of the lung: a case report

    Cancer Biology and Therapy, Vol. 16, Núm. 10, pp. 1434-1437

  15. SEOM clinical guidelines in metastatic breast cancer 2015

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 946-955

  16. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 9, pp. 1378-1389

  17. Supervised physical exercise to improve the quality of life of cancer patients: The Eficancer randomised controlled trial

    BMC Cancer, Vol. 15, Núm. 1

  18. The circulating transcriptome as a source of non-invasive cancer biomarkers: Concepts and controversies of non-coding and coding RNA in body fluids

    Journal of Cellular and Molecular Medicine, Vol. 19, Núm. 10, pp. 2307-2323